{"id":342665,"date":"2026-11-09T18:15:49","date_gmt":"2026-11-09T12:45:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/"},"modified":"2026-11-09T18:15:49","modified_gmt":"2026-11-09T12:45:49","slug":"medico-remedies-q2-results-fy27-pat-2-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/","title":{"rendered":"Medico Remedies Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 73.97 Cr, PAT Rs 2.38 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Medico Remedies Q2 Results FY27 were declared on 9 November 2026, with Standalone revenue of Rs 73.97 Cr, up 40.52% YoY from Rs 52.64 Cr, and net profit of Rs 2.38 Cr, down 7.39% from Rs 2.57 Cr. These quarterly results also show YoY growth in Operating Profit of 16.54% to Rs 3.17 Cr from Rs 2.72 Cr, so revenue and Operating Profit rose while net profit eased.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/medico\/medico-remedies-ltd-share-price-today\">Medico Remedies Ltd<\/a> (MEDICO) Q2 Results FY27 announced on 9 November 2026, covering the company&#8217;s financial performance for the July to September quarter. The company reported Standalone revenue of Rs 73.97 Cr and PAT of Rs 2.38 Cr. The results date of 9 November 2026 anchors these standalone results, and Medico Remedies Q2 Results FY27 are analysed here using verified figures only.<\/p>\n<p>This Medico Remedies Q2 Results results analysis covers the financial highlights, business drivers, outlook and risks, with Operating Profit and net profit set against revenue. Univest has arranged the results analysis in a fixed order so the numbers can be read quickly, starting with the financial highlights.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Medico_Remedies_Q2_Results_FY27_Financial_Highlights\" title=\"Medico Remedies Q2 Results FY27: Financial Highlights\">Medico Remedies Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Key_Takeaways_from_Medico_Remedies_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Medico Remedies Q2 Results: What Stands Out\">Key Takeaways from Medico Remedies Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Medico_Remedies_Q2_Results_FY27_Performance_Analysis\" title=\"Medico Remedies Q2 Results FY27: Performance Analysis\">Medico Remedies Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#FY27_Outlook_After_Medico_Remedies_Q2_Results\" title=\"FY27 Outlook After Medico Remedies Q2 Results\">FY27 Outlook After Medico Remedies Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Key_Risks_to_Watch_After_Medico_Remedies_Q2_Results_FY27\" title=\"Key Risks to Watch After Medico Remedies Q2 Results FY27\">Key Risks to Watch After Medico Remedies Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Net_Profit_Fell_74_YoY\" title=\"Net Profit Fell 7.4% YoY\">Net Profit Fell 7.4% YoY<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Net_Profit_Margin_at_32\" title=\"Net Profit Margin at 3.2%\">Net Profit Margin at 3.2%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Volatile_Quarterly_Net_Profit\" title=\"Volatile Quarterly Net Profit\">Volatile Quarterly Net Profit<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Frequently_Asked_Questions_on_Medico_Remedies_Q2_Results_FY27\" title=\"Frequently Asked Questions on Medico Remedies Q2 Results FY27\">Frequently Asked Questions on Medico Remedies Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_are_Medico_Remedies_Q2_Results_FY27\" title=\"What are Medico Remedies Q2 Results FY27?\">What are Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_is_the_results_date_for_Medico_Remedies_Q2_Results_FY27\" title=\"What is the results date for Medico Remedies Q2 Results FY27?\">What is the results date for Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_revenue_was_reported_in_Medico_Remedies_Q2_Results_FY27\" title=\"What revenue was reported in Medico Remedies Q2 Results FY27?\">What revenue was reported in Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_net_profit_was_reported_in_Medico_Remedies_Q2_Results_FY27\" title=\"What net profit was reported in Medico Remedies Q2 Results FY27?\">What net profit was reported in Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#How_much_YoY_growth_did_revenue_show_in_Medico_Remedies_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Medico Remedies Q2 Results FY27?\">How much YoY growth did revenue show in Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Did_net_profit_rise_or_fall_in_Medico_Remedies_Q2_Results\" title=\"Did net profit rise or fall in Medico Remedies Q2 Results?\">Did net profit rise or fall in Medico Remedies Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_was_the_Operating_Profit_in_Medico_Remedies_Q2_Results_FY27\" title=\"What was the Operating Profit in Medico Remedies Q2 Results FY27?\">What was the Operating Profit in Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Are_Medico_Remedies_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are Medico Remedies Q2 Results consolidated results or standalone results?\">Are Medico Remedies Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_business_factors_shaped_Medico_Remedies_Q2_Results_FY27\" title=\"What business factors shaped Medico Remedies Q2 Results FY27?\">What business factors shaped Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_are_the_key_risks_after_Medico_Remedies_Q2_Results_FY27\" title=\"What are the key risks after Medico Remedies Q2 Results FY27?\">What are the key risks after Medico Remedies Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#What_is_the_outlook_after_Medico_Remedies_Q2_Results\" title=\"What is the outlook after Medico Remedies Q2 Results?\">What is the outlook after Medico Remedies Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-q2-results-fy27-pat-2-crore\/#Where_can_I_find_the_complete_Medico_Remedies_Q2_Results_FY27_data\" title=\"Where can I find the complete Medico Remedies Q2 Results FY27 data?\">Where can I find the complete Medico Remedies Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Medico_Remedies_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Medico Remedies Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 73.97 Cr<\/td>\n<td>Rs 52.64 Cr<\/td>\n<td>+40.52% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 3.17 Cr<\/td>\n<td>Rs 2.72 Cr<\/td>\n<td>+16.54% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 2.38 Cr<\/td>\n<td>Rs 2.57 Cr<\/td>\n<td>-7.39% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Medico Remedies Q2 Results FY27, 9 November 2026. Figures in Rs Crore, Standalone basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Medico_Remedies_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Medico Remedies Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue of Rs 73.97 Cr<\/strong> rose 40.52% YoY from Rs 52.64 Cr, which is the main YoY growth reading in Medico Remedies Q2 Results FY27.<\/li>\n<li><strong>Operating Profit of Rs 3.17 Cr<\/strong> rose 16.54% YoY from Rs 2.72 Cr, so profit at the operating level grew more slowly than revenue.<\/li>\n<li><strong>Net profit of Rs 2.38 Cr<\/strong> fell 7.39% YoY from Rs 2.57 Cr, which is the one headline line that moved against revenue.<\/li>\n<li><strong>Net profit margin narrowed to 3.2%<\/strong> from 4.9% in the comparison quarter, which is a risk flagged in the quarterly data.<\/li>\n<li><strong>Return on equity was 19.02%<\/strong> and return on capital employed was 23.28% in FY26, which leads into the performance analysis.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Medico_Remedies_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Medico Remedies Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medico Remedies Q2 Results FY27 show revenue of Rs 73.97 Cr against Rs 52.64 Cr a year earlier, a YoY growth of 40.52%, while Operating Profit rose 16.54% to Rs 3.17 Cr. Net profit, however, eased 7.39% to Rs 2.38 Cr from Rs 2.57 Cr, so the quarterly results show revenue and net profit moving in opposite directions.<\/p>\n<p>Operating Profit grew by less than revenue, and net profit slipped while sales rose, which is why the net profit margin of 3.2% sits below the 4.9% of the comparison quarter. This standalone results picture is the core of the Medico Remedies Q2 Results FY27 results analysis.<\/p>\n<p>For this Medico Remedies Q2 Results results analysis, later quarterly results will show whether the YoY growth in revenue starts to carry through to net profit. That question leads to the business factors listed in the data.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth Year on Year<\/strong> &#8211; The business factors start with revenue, which grew 40.5% year on year to Rs 73.97 Cr in the latest quarter, the strongest supportive figure in Medico Remedies Q2 Results FY27 and a key part of the quarterly results.<\/p>\n<p><strong>Return on Equity at 19.02%<\/strong> &#8211; Return on equity was 19.02% in FY26, which describes the profitability earned on shareholders&#8217; funds over the last financial year and gives context for the latest quarter&#8217;s earnings.<\/p>\n<p><strong>Return on Capital Employed at 23.28%<\/strong> &#8211; Return on capital employed was 23.28% in FY26, which describes the profit earned on the capital used in the business over the last financial year, alongside the equity return.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Medico_Remedies_Q2_Results\"><\/span><strong>FY27 Outlook After Medico Remedies Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 full-year picture will depend on the quarters still to be reported and on conditions disclosed by the company and its sector. This results analysis therefore treats the latest figures as one data point in FY27, and net profit will be the line to follow.<\/p>\n<p>Within Medico Remedies Q2 Results FY27, revenue growth of 40.52% and a net profit decline of 7.39% set up the main comparison for later quarters. Readers can follow those filings on the Univest Screener and the Univest app, and the risks below are best monitored there.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Medico Remedies Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Net_Profit_Fell_74_YoY\"><\/span><strong>Net Profit Fell 7.4% YoY<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit fell 7.4% year on year to Rs 2.38 Cr even as revenue grew, so the direction of the bottom line is the first item to watch in later disclosures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Net_Profit_Margin_at_32\"><\/span><strong>Net Profit Margin at 3.2%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Within Medico Remedies Q2 Results FY27, the net profit margin narrowed to 3.2% from 4.9% in the comparison quarter, so a smaller share of each rupee of revenue reached net profit than a year earlier.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Volatile_Quarterly_Net_Profit\"><\/span><strong>Volatile Quarterly Net Profit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Quarterly net profit has been volatile, ranging from Rs 2.38 Cr to Rs 5.86 Cr over the last 5 quarters, so YoY growth in one line may not carry into the next quarter.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medico Remedies Q2 Results FY27 show revenue growth of 40.52% YoY to Rs 73.97 Cr, Operating Profit up 16.54% to Rs 3.17 Cr and net profit down 7.39% to Rs 2.38 Cr. In summary, these quarterly results pair a strong top line with a lower bottom line. The wider read on Medico Remedies Q2 Results depends on how the standalone results develop in the quarters still to come. Investors should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Medico Remedies Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What are Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medico Remedies Q2 Results FY27 cover the July to September 2026 quarter, with Standalone revenue of Rs 73.97 Cr and net profit of Rs 2.38 Cr, as set out in the Financial Highlights table of this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What is the results date for Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The results date for Medico Remedies Q2 Results FY27 is 9 November 2026, when the company declared its quarterly results, so every figure in the Financial Highlights table reflects that filing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medico Remedies reported revenue of Rs 73.97 Cr in the quarter, up from Rs 52.64 Cr a year earlier, which means the top line grew 40.52% as shown in the Performance Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit in Medico Remedies Q2 Results FY27 was Rs 2.38 Cr, compared with Rs 2.57 Cr a year earlier, a fall of 7.39%, as the Performance Analysis section explains in detail.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed YoY growth of 40.52% in Medico Remedies Q2 Results FY27, rising to Rs 73.97 Cr, while Operating Profit grew 16.54%, as covered under Performance Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Medico_Remedies_Q2_Results\"><\/span><strong>Did net profit rise or fall in Medico Remedies Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit fell in Medico Remedies Q2 Results, down 7.39% to Rs 2.38 Cr from Rs 2.57 Cr, which means the bottom line moved against the direction of revenue growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit in Medico Remedies Q2 Results FY27 was Rs 3.17 Cr, up 16.54% from Rs 2.72 Cr a year earlier, while net profit moved the other way, as the Key Takeaways section shows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_Medico_Remedies_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are Medico Remedies Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medico Remedies Q2 Results are standalone results, reported on a Standalone basis with revenue of Rs 73.97 Cr, so the figures in the Financial Highlights table are not consolidated numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What business factors shaped Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The business factors in Medico Remedies Q2 Results FY27 include revenue growth of 40.5% year on year, return on equity of 19.02% and return on capital employed of 23.28% in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Medico_Remedies_Q2_Results_FY27\"><\/span><strong>What are the key risks after Medico Remedies Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks after Medico Remedies Q2 Results FY27 are the 7.4% fall in net profit, the margin narrowing to 3.2% from 4.9%, and volatile quarterly net profit, as the Key Risks section sets out.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Medico_Remedies_Q2_Results\"><\/span><strong>What is the outlook after Medico Remedies Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The FY27 outlook after Medico Remedies Q2 Results will depend on the quarters still to be reported, so this quarter is one data point, which the Outlook section treats alongside the net profit trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Medico_Remedies_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Medico Remedies Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Medico Remedies Q2 Results FY27 data sits in the Financial Highlights table above, and readers can also check the Univest Screener and the Univest app for later quarterly results.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medico Remedies Q2 Results FY27 cover the July to September 2026 quarter, with Standalone revenue of Rs 73.97 Cr and net profit of Rs 2.38 Cr, as set out in the Financial Highlights table of this article.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The results date for Medico Remedies Q2 Results FY27 is 9 November 2026, when the company declared its quarterly results, so every figure in the Financial Highlights table reflects that filing.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medico Remedies reported revenue of Rs 73.97 Cr in the quarter, up from Rs 52.64 Cr a year earlier, which means the top line grew 40.52% as shown in the Performance Analysis.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit in Medico Remedies Q2 Results FY27 was Rs 2.38 Cr, compared with Rs 2.57 Cr a year earlier, a fall of 7.39%, as the Performance Analysis section explains in detail.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed YoY growth of 40.52% in Medico Remedies Q2 Results FY27, rising to Rs 73.97 Cr, while Operating Profit grew 16.54%, as covered under Performance Analysis.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Medico Remedies Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit fell in Medico Remedies Q2 Results, down 7.39% to Rs 2.38 Cr from Rs 2.57 Cr, which means the bottom line moved against the direction of revenue growth.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit in Medico Remedies Q2 Results FY27 was Rs 3.17 Cr, up 16.54% from Rs 2.72 Cr a year earlier, while net profit moved the other way, as the Key Takeaways section shows.\"}},{\"@type\":\"Question\",\"name\":\"Are Medico Remedies Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medico Remedies Q2 Results are standalone results, reported on a Standalone basis with revenue of Rs 73.97 Cr, so the figures in the Financial Highlights table are not consolidated numbers.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The business factors in Medico Remedies Q2 Results FY27 include revenue growth of 40.5% year on year, return on equity of 19.02% and return on capital employed of 23.28% in FY26.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Medico Remedies Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key risks after Medico Remedies Q2 Results FY27 are the 7.4% fall in net profit, the margin narrowing to 3.2% from 4.9%, and volatile quarterly net profit, as the Key Risks section sets out.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Medico Remedies Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY27 outlook after Medico Remedies Q2 Results will depend on the quarters still to be reported, so this quarter is one data point, which the Outlook section treats alongside the net profit trend.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Medico Remedies Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Medico Remedies Q2 Results FY27 data sits in the Financial Highlights table above, and readers can also check the Univest Screener and the Univest app for later quarterly results.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Medico Remedies Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 73.97 Cr, PAT Rs 2.38 Cr\",\"description\":\"Medico Remedies Q2 Results: Standalone revenue \u20b973.97 Cr, PAT \u20b92.38 Cr. Check YoY growth and quarterly results analysis from the 9 November 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Medico Remedies Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medico Remedies Q2 Results FY27: Standalone revenue Rs 73.97 Cr, up 40.52% YoY, with net profit of Rs 2.38 Cr declared on 9 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":342664,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-342665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["342664"],"rank_math_title":["Medico Remedies Q2 Results FY27: Revenue Up 40.52%"],"rank_math_description":["Medico Remedies Q2 Results: Standalone revenue \u20b973.97 Cr, PAT \u20b92.38 Cr. Check YoY growth and quarterly results analysis from the 9 November 2026 filing."],"rank_math_focus_keyword":["Medico Remedies Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/medico-remedies-q2-results-fy27-profit-moves-against-revenue-revenue-rs-73-97-cr.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/342665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=342665"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/342665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/342664"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=342665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=342665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=342665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}